News and Press Releases

Contact Veristat Now

Request A Proposal

Contact Us

Veristat Acknowledged on Boston Business Journal’s “Fast 50” List for a Second Consecutive Year

Ranked as one of the Top 50 Fastest Growing Private Companies in Massachusetts

Read More

Veristat Opens New Office in North Carolina Today

Veristat announced today the official opening of its new office in Morrisville, NC. 
Read More

Veristat Appoints James Roach, MD as Chief Medical Officer

Veristat Strengthens its Clinical Operations, Medical and Regulatory Affairs Offerings

SOUTHBOROUGH, MA – November 07, 2016 – Veristat announced that it has appointed James (Jim) Roach, MD, FACP, FCCP as its new Chief Medical Officer to bolster the expansion of its clinical operations, medical and regulatory affairs offerings.
Read More

Veristat Formalizes its Strategic Decision Consulting Services

SOUTHBOROUGH, MA –  November 01, 2016Veristat, a full service consultative Clinical Research Organization (CRO), announced today the formal launch of its Strategic Decision Consulting service offering to help pharmaceutical, biotechnology and medical device firms solve the unique and complex challenges they face throughout the development process.  

Read More

Veristat Strengthens Its Long-Standing Relationship with Aegerion Pharmaceuticals

Veristat, a full service Clinical Research Organization (CRO), announced today the signing of a Preferred Provider Agreement (PPA) with Aegerion Pharmaceuticals Inc. (“Aegerion”), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.  Veristat has assisted Aegerion with US Food and Drug Administration, EU Market Authorization Application, and Japan Food and Drug Administration submission projects over the past 5 years.

Read More

Veristat Acknowledged for its Rapid Growth on the Inc. 5000 List of America’s Fastest-Growing Private Companies

Veristat Continues To Be Recognized for Its Positive Impact & Company Growth

SOUTHBOROUGH, MA – August 17, 2016Veristat announced today that it has been recognized once again by Inc. Magazine as one of America’s fastest-growing private companies. Veristat debuted on the list in 2015.

Read More

Veristat Article “Adaptive Designs- Recent Advancement in Clinical Trials” Published in “Journal of Bioanalysis & Biostatistics”

Two of Veristat’s statistical and adaptive design experts submitted a research paper which was published in the June 2016 issue of the Journal of Bioanalysis & Biostatistics.

Read More

Fueled by Growth, Veristat Continues Geographic Expansion in North Carolina

Accelerates Hiring & Plans to Open Office in Raleigh-Durham, North Carolina


Read More

Veristat Strengthens Statistical Consulting and Adaptive Design Trial Expertise With Appointment of Mark Chang

Appoints Mark Chang as Senior Vice President of Strategic Statistical Consulting


SOUTHBOROUGH, MA – June 15, 2016Veristat, a full service Clinical Research Organization (CRO), announced that it has strengthened its statistical consulting and adaptive design expertise with the appointment of Mark Chang, PhD to the newly created position of Senior Vice President of Strategic Statistical Consulting.   Dr. Chang will help clients evaluate and implement strategic, operational and technical efficiencies to advance products through the clinical trial and regulatory submission process.

Read More

Veristat Expands Its Clinical Operations into Europe - Acquires UK-based CRO, Spero Oncology

SOUTHBOROUGH, MA – May 2, 2016Veristat, a full service Clinical Research Organization (CRO), announced today that it is expanding its clinical research offerings into Europe through the acquisition of UK-based CRO, Spero Oncology.   Spero Oncology is a UK-based CRO specializing in providing clinical operations support for oncology clinical trials primarily throughout Europe, but also in Australia and New Zealand. With the acquisition of Spero Oncology, Veristat now offers its clients full clinical operations support in Europe including feasibility studies, legal representation in the European Union, Clinical Monitoring, Project Management, Protocol Writing and Regulatory Strategy.

Read More